[{"Assets_0_Q1_USD":49004000000.0,"CIK":"818686","CommonStockSharesConverted_0_Q1_shares":1208000000.0,"Country":"Israel","EarningsPerShareBasic_1_Q1_USD":0.07,"EarningsPerShareDiluted_1_Q1_USD":0.07,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"11303387401.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-405000000.0,"NetIncomeLossConverted_1_Q1_USD":77000000.0,"OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","RevenuesConverted_1_Q1_USD":3982000000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":10975000000.0,"StockholdersEquity_0_Q1_USD":10000000000.0,"Ticker":"TEVA","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1107000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1099000000.0,"filed":"20210428","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2021.0","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","period":"20210331","qtrs":"1","uom":"USD"}]